Try it
Pharmacology · Adrenergic drugs: beta2 agonist in hyperkalaemia
Sample itemA 55-year-old man on dialysis has serum potassium 6.9 mmol/L with peaked T waves and has received intravenous calcium gluconate. Which additional drug lowers serum potassium by a beta2-mediated shift of potassium into cells?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Nebulised salbutamol
Beta2 stimulation activates the sodium-potassium ATPase in skeletal muscle and drives potassium into cells, so nebulised salbutamol is a recognised temporising measure for hyperkalaemia alongside insulin with glucose. A non-selective beta-blocker does the reverse and impairs potassium uptake.
Option by option
A. Intravenous propranolol
Propranolol blocks beta2 receptors and can raise serum potassium.
B. Nebulised ipratropium
Ipratropium is an antimuscarinic bronchodilator with no effect on cellular potassium uptake.
C. Nebulised salbutamol (correct)
Correct. Beta2 stimulation of Na-K ATPase moves potassium intracellularly.
D. Intravenous phenylephrine
Phenylephrine is an alpha1 agonist and does not act on the beta2 pump mechanism.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?